These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 7459221

  • 1. In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: cyclophosphamide and BCNU.
    Tannock IF.
    Br J Cancer; 1980 Dec; 42(6):871-80. PubMed ID: 7459221
    [Abstract] [Full Text] [Related]

  • 2. In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: methotrexate, 5-fluorouracil and adriamycin.
    Tannock IF.
    Br J Cancer; 1980 Dec; 42(6):861-70. PubMed ID: 7459220
    [Abstract] [Full Text] [Related]

  • 3. Modification of tumour and host response to cyclophosphamide by misonidazole and by WR 2721.
    Twentyman PR.
    Br J Cancer; 1981 Jun; 43(6):745-55. PubMed ID: 6264941
    [Abstract] [Full Text] [Related]

  • 4. Time-dose relationships for simultaneous misonidazole and 1,3-bis(2-chloroethyl)-1-nitrosourea exposures in vitro.
    Mulcahy RT, Dembs N.
    Cancer Res; 1983 Aug; 43(8):3539-43. PubMed ID: 6861127
    [Abstract] [Full Text] [Related]

  • 5. Nitrosourea-misonidazole combination chemotherapy: effect on KHT sarcomas, marrow stem cells and gut.
    Mulcahy RT, Siemann DW, Sutherland RM.
    Br J Cancer; 1982 Jun; 45(6):835-42. PubMed ID: 6212075
    [Abstract] [Full Text] [Related]

  • 6. In vivo response of KHT sarcomas to combination chemotherapy with radiosensitizers and BCNU.
    Mulcahy RT, Siemann DW, Sutherland RM.
    Br J Cancer; 1981 Jan; 43(1):93-9. PubMed ID: 7459244
    [Abstract] [Full Text] [Related]

  • 7. Enhancing effect of misonidazole on the response of the RIF-1 tumour to cyclophosphamide.
    Law MP, Hirst DG, Brown JM.
    Br J Cancer; 1981 Aug; 44(2):208-18. PubMed ID: 7272187
    [Abstract] [Full Text] [Related]

  • 8. Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.
    Siemann DW.
    Br J Cancer; 1982 Feb; 45(2):272-81. PubMed ID: 6460517
    [Abstract] [Full Text] [Related]

  • 9. The advantageous use of hypoxic tumour cells in cancer therapy: identical chemosensitization by metronidazole and misonidazole at moderately elevated temperatures.
    Urano M, Wong KH, Reynolds R, Begley J.
    Int J Hyperthermia; 1995 Feb; 11(3):379-88. PubMed ID: 7636324
    [Abstract] [Full Text] [Related]

  • 10. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
    Mulcahy RT, Siemann DW.
    Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329
    [Abstract] [Full Text] [Related]

  • 11. Comparative study of thermoradiosensitization by misonidazole and metronidazole in vivo: antitumour effect and pharmacokinetics.
    Wong KH, Maezawa H, Urano M.
    Int J Hyperthermia; 1992 Oct; 8(5):645-58. PubMed ID: 1402141
    [Abstract] [Full Text] [Related]

  • 12. Enhancement of the effect of cytotoxic drugs by radiosensitizers.
    Martin WM, McNally NJ, De Ronde J.
    Br J Cancer; 1981 Jun; 43(6):756-66. PubMed ID: 7248157
    [Abstract] [Full Text] [Related]

  • 13. Enhancement of misonidazole chemosensitization effect by mild local hyperthermia.
    Wong KH, Urano M.
    Int J Radiat Oncol Biol Phys; 1992 Jun; 23(3):593-8. PubMed ID: 1612960
    [Abstract] [Full Text] [Related]

  • 14. Effect of misonidazole or metronidazole pretreatment on the response of the RIF-1 mouse sarcoma to melphalan, cyclophosphamide, chlorambucil and CCNU.
    Twentyman P, Workman P.
    Br J Cancer; 1982 Mar; 45(3):447-55. PubMed ID: 7073938
    [Abstract] [Full Text] [Related]

  • 15. Misonidazole increases the toxicity of BCNU for hypoxic cells.
    Tannock I, Guttman P.
    Int J Radiat Oncol Biol Phys; 1982 Mar; 8(3-4):663-6. PubMed ID: 7107395
    [Abstract] [Full Text] [Related]

  • 16. Effect of clinical levels of misonidazole on the response of tumour and normal tissues in the mouse to alkylating agents.
    Brown JM, Hirst DG.
    Br J Cancer; 1982 May; 45(5):700-8. PubMed ID: 7082556
    [Abstract] [Full Text] [Related]

  • 17. Enhancement of the action of alkylating agents by single high, or chronic low doses of misonidazole.
    McNally NJ, Hinchliffe M, de Ronde J.
    Br J Cancer; 1983 Aug; 48(2):271-8. PubMed ID: 6882665
    [Abstract] [Full Text] [Related]

  • 18. In vivo interaction between radiation and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the absence or presence of misonidazole in mice.
    Siemann DW, Maddison K, Wolf K, Hill SA, Keng PC.
    Cancer Res; 1985 Jan; 45(1):198-202. PubMed ID: 3965132
    [Abstract] [Full Text] [Related]

  • 19. Effect of tumor size on S-2-(3-aminopropylamino)ethylphosphorothioic acid and misonidazole alteration of tumor response to cyclophosphamide.
    Milas L, Ito H, Hunter N.
    Cancer Res; 1983 Jul; 43(7):3050-6. PubMed ID: 6303574
    [Abstract] [Full Text] [Related]

  • 20. Hypoxic cells and in situ chemopotentiation of the nitrosoureas by misonidazole.
    Wheeler KT, Wallen CA, Wolf KL, Siemann DW.
    Br J Cancer; 1984 Jun; 49(6):787-93. PubMed ID: 6733024
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.